Pharming Group N.V.
PHAR
$13.96
$0.5594.17%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 126.01M | 167.89M | 160.32M | 201.97M | |
| Total Receivables | 53.33M | 50.17M | 51.12M | 38.70M | |
| Inventory | 63.72M | 55.72M | 59.19M | 55.88M | |
| Prepaid Expenses | -- | 4.65M | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 2.73M | -- | -- | -- | |
| Total Current Assets | 245.78M | 278.44M | 270.63M | 296.55M | |
|
|
|||||
| Total Current Assets | 245.78M | 278.44M | 270.63M | 296.55M | |
| Net Property, Plant & Equipment | 24.57M | 24.13M | 30.72M | 31.86M | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 135.90M | 61.04M | 66.57M | 68.30M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 33.32M | 32.14M | 40.64M | 37.28M | |
| Total Assets | 446.26M | 399.99M | 415.93M | 441.67M | |
|
|
|||||
| Total Accounts Payable | 78.38M | 10.10M | 72.97M | 68.52M | |
| Total Accrued Expenses | -- | 53.22M | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 9.56M | 7.19M | 6.97M | 138.77M | |
| Total Finance Division Other Current Liabilities | -- | 3.28M | -- | -- | |
| Total Other Current Liabilities | -- | 3.28M | -- | -- | |
| Total Current Liabilities | 87.94M | 73.80M | 79.94M | 207.29M | |
|
|
|||||
| Total Current Liabilities | 87.94M | 73.80M | 79.94M | 207.29M | |
| Long-Term Debt | 91.27M | 78.15M | 87.32M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 27.50M | 26.97M | 27.73M | 28.44M | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 206.71M | 178.92M | 194.99M | 235.72M | |
|
|
|||||
| Common Stock & APIC | 499.67M | 496.76M | 494.60M | 487.34M | |
| Retained Earnings | -260.12M | -287.92M | -273.66M | -558.79M | |
| Treasury Stock & Other | -- | 12.23M | -- | -4.00M | |
| Total Common Equity | 239.55M | 221.06M | 220.94M | 205.95M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 239.55M | 221.06M | 220.94M | 205.95M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 239.55M | 221.06M | 220.94M | 205.95M | |
|
|
|||||